Shattuck Labs
Thomas joined Shattuck in April 2018 as Head of Regulatory Affairs. He has more than 22 years of experience at GlaxoSmithKline, most recently as a Senior Director in Global Regulatory Affairs responsible for regulatory strategy and leading regulatory teams for global and US focused programs. Prior to regulatory affairs, Thomas was a Senior Director within oncology clinical development at GSK, leading global clinical development teams for multiple solid tumor and hematologic malignancy programs. In both regulatory and clinical roles, he has experience spanning drug development from prior to candidate selection through approval to market. Thomas was previously a co-founder and Director of the Clinical Research Center at Sarasota Memorial Hospital in Florida, an Assistant Director in the Department of Pharmaceutical Services, and Coordinator of the Institutional Review Board. Thomas has a Doctor of Pharmacy degree from University of Illinois at Chicago, and completed a Fellowship in Clinical Research and Drug Development at The University of North Carolina at Chapel Hill.
This person is not in any offices
Shattuck Labs
Shattuck is a clinical-stage biotechnology company pioneering the development of bifunctional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease.